🇺🇸 FDA
Patent

US 11576984

Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using

granted A61KA61K49/0008

Quick answer

US patent 11576984 (Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K49/0008